Cancers Journal Publishes Special Issue Dedicated to OGM’s Impact on Hematological Malignancy Research
SAN DIEGO, Dec. 14, 2023 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq:BNGO), today announced the publication of a special issue of Cancers journal entirely dedicated to the Company’s optical genome mapping (OGM) workflow. The issue, which features guest editors Dr. Adam Smith from University of Toronto, Dr. Gordana Raca from Children’s Hospital Los Angeles, and Dr. Alexander Hoischen from Radboud University Medical Center, includes eight peer-reviewed publications, with three additional publications expected to come, covering the use of OGM in hematological malignancy research and demonstrating its potential to offer significant research insights in a simple and effective workflow.
Related news for (BNGO)
- Don’t Miss Out: MoBot’s Latest Stock Updates 04/10/25 03:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 04/10/25 02:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 04/10/25 01:00 PM
- Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing